ScholarIQanswers from OpenAlex & ORCID
Derralynn Hughes
ResearcherPublications, citations & collaboration network
Derralynn Hughes is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Derralynn Hughes have?
ScholarIQindexed works
Derralynn Hughes has 700 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Derralynn Hughes have?
ScholarIQcitation count
Derralynn Hughes has 18,737 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Derralynn Hughes?
ScholarIQh-index
Derralynn Hughes has an h-index of 75 in OpenAlex.
What is the i10-index of Derralynn Hughes?
ScholarIQi10-index
Derralynn Hughes has an i10-index of 238 in OpenAlex.
What is the ORCID of Derralynn Hughes?
ScholarIQorcid
The ORCID for Derralynn Hughes is on the source record.
What is the OpenAlex record for Derralynn Hughes?
ScholarIQopenalex
The OpenAlex for Derralynn Hughes is on the source record.
What are the most-cited papers on Derralynn Hughes?
ScholarIQmost cited works
Treatment of Fabry’s Disease with the Pharmacologic Chaperone Migalastat
Dominique P. Germain, Derralynn Hughes, Kathy Nicholls, Daniel G. Bichet, Roberto Giugliani, William R. Wilcox, Claudio Feliciani, Suma P. Shankar, Fatih Süheyl Ezgü, Hernan Amartino, Drago Bratkovic, Ulla Feldt‐Rasmussen, Khan Nedd, Usama Sharaf El Din, Charles Marques Lourenço, Maryam Banikazemi, Joel Charrow, Majed Dasouki, David N. Finegold, Pilar Giraldo, Özlem Göker-Alpan, Nicola Longo, C. Ronald Scott, Roser Torrá, Ahmad Tuffaha, Ana Jovanović, Stephen Waldek, Seymour Packman, Elizabeth Ludington, Christopher Viereck, John Kirk, Julie Yu, Elfrida R. Benjamin, Franklin K. Johnson, David J. Lockhart, Nina Skuban, Jeff Castelli, Jay Barth, Carrolee Barlow, Raphael Schiffmann
Oral pharmacological chaperone migalastat compared with enzyme replacement therapy in Fabry disease: 18-month results from the randomised phase III ATTRACT study
Derralynn Hughes, Kathy Nicholls, Suma P. Shankar, Gere Sunder–Plassmann, David M. Koeller, Khan Nedd, Gerard Vockley, Takashi Hamazaki, Robin Lachmann, Toya Ohashi, Iacopo Olivotto, Norio Sakai, Patrick Deegan, David Dimmock, François Eyskens, Dominique P. Germain, Özlem Göker-Alpan, É. Hachulla, Ana Jovanović, Charles Marques Lourenço, Ichiei Narita, Mark Thomas, William R. Wilcox, Daniel G. Bichet, Raphael Schiffmann, Elizabeth Ludington, Christopher Viereck, John Kirk, Julie Yu, Franklin K. Johnson, Pol Boudes, Elfrida R. Benjamin, David J. Lockhart, Carrolee Barlow, Nina Skuban, Jeffrey P. Castelli, Jay Barth, Ulla Feldt‐Rasmussen
Recommendations for initiation and cessation of enzyme replacement therapy in patients with Fabry disease: the European Fabry Working Group consensus document
Marieke Biegstraaten, Reynir Arngrı́msson, Frédéric Barbey, Lut Boks, Franco Cecchi, Patrick Deegan, Ulla Feldt‐Rasmussen, Tarekegn Geberhiwot, Dominique P. Germain, Christian J. Hendriksz, Derralynn Hughes, Ilkka Kantola, Nesrin Karabul, Christine Lavery, Gabor E. Linthorst, Atul Mehta, Erica van de Mheen, João Paulo Oliveira, Rossella Parini, Uma Ramaswami, Michael Rudnicki, Andreas L. Serra, Claudia Sommer, Gere Sunder–Plassmann, Einar Svarstad, Annelies Sweeb, Wim Terryn, Anna Tylki‐Szymańska, Camilla Tøndel, Bojan Vujkovac, Frank Weidemann, Frits A. Wijburg, Peter Woolfson, Carla E. M. Hollak
An Expert Consensus Document on the Management of Cardiovascular Manifestations of Fabry Disease
Aleš Linhart, Dominique P. Germain, Iacopo Olivotto, Mohammed Akhtar, Aris Anastasakis, Derralynn Hughes, Mehdi Namdar, Maurizio Pieroni, Albert Hagège, Franco Cecchi, Juan R. Gimeno, Giuseppe Limongelli, Perry Elliott
Efficacy and safety of enzyme replacement therapy with BMN 110 (elosulfase alfa) for Morquio A syndrome (mucopolysaccharidosis IVA): a phase 3 randomised placebo‐controlled study
Christian J. Hendriksz, Barbara K. Burton, Thomas R. Fleming, Paul Harmatz, Derralynn Hughes, Simon Jones, Hsiang‐Yu Lin, Eugen Mengel, Maurizio Scarpa, Vassili Valayannopoulos, Roberto Giugliani, STRIVE Investigators, Peter Slasor, Debra L. Lounsbury, Wolfgang Dummer